نسبة التغطية بالتطعيم حسب الدولة (% من الأطفال بعمر 12–23 شهرًا)
| الدولة | الحصبة (MCV1) | DTP3 | HepB3 |
|---|---|---|---|
|
|
84.3% | 84.8% | 84.4% |
|
|
23% | 81% | 61% |
|
|
41% | 42% | 42% |
|
|
41% | 42% | 42% |
|
|
44% | 63% | 63% |
|
|
44% | 42% | 42% |
|
|
46% | 60% | 60% |
|
|
46% | 39% | 39% |
|
|
53% | 64% | 64% |
|
|
53% | 68% | 68% |
|
|
55% | 59% | 59% |
|
|
55% | 65% | 65% |
|
|
57% | 61% | 61% |
|
|
57% | 67% | 67% |
|
|
60% | 63% | 63% |
|
|
61% | 71% | 71% |
|
|
64% | 70% | 70% |
|
|
65% | 68% | 68% |
|
|
65% | 70% | 70% |
|
|
66% | 68% | 68% |
|
|
67% | 59% | 59% |
|
|
67% | 49% | 46% |
|
|
69% | 79% | 82% |
|
|
69% | 67% | 67% |
|
|
70% | 75% | 75% |
|
|
71% | 51% | 51% |
|
|
71% | 77% | 77% |
|
|
71% | 71% | 71% |
|
|
71% | 62% | 62% |
|
|
72% | 78% | 78% |
|
|
72% | 83% | 83% |
|
|
72% | 73% | 73% |
|
|
72% | 82% | 82% |
|
|
72% | 73% | 73% |
|
|
73% | 89% | 91% |
|
|
73% | 69% | 69% |
|
|
74% | 70% | 70% |
|
|
75% | 77% | 77% |
|
|
75% | 77% | 77% |
|
|
76% | 74% | 74% |
|
|
77% | 60% | 60% |
|
|
78% | 79% | 79% |
|
|
78% | 87% | 87% |
|
|
79% | 75% | 75% |
|
|
79% | 94% | 94% |
|
|
79% | 74% | 74% |
|
|
80% | 90% | 90% |
|
|
80% | 78% | 78% |
|
|
80% | 71% | 71% |
|
|
81% | 97% | 97% |
|
|
81% | 86% | 86% |
|
|
81% | 73% | 73% |
|
|
81% | 90% | 90% |
|
|
82% | 75% | 75% |
|
|
82% | 83% | 83% |
|
|
83% | 83% | 83% |
|
|
83% | 81% | 81% |
|
|
83% | 80% | 80% |
|
|
83% | 93% | 86% |
|
|
83% | 99% | 99% |
|
|
84% | 88% | 88% |
|
|
84% | 86% | 88% |
|
|
84% | 95% | 93% |
|
|
84% | 83% | 83% |
|
|
85% | 84% | 84% |
|
|
85% | 78% | 78% |
|
|
85% (2023) | 89% (2023) | 89% (2023) |
|
|
85% | 85% | 85% |
|
|
85% | 88% | 88% |
|
|
86% | 90% | 90% |
|
|
86% | 89% | 89% |
|
|
86% | 89% | 87% |
|
|
86% | 87% | 87% |
|
|
87% | 87% | 87% |
|
|
87% | 91% | 91% |
|
|
88% | 94% | 94% |
|
|
88% | 91% | 91% |
|
|
88% | 91% | 91% |
|
|
88% | 97% | 97% |
|
|
88% | 85% | 89% |
|
|
88% | 99% | 99% |
|
|
88% | 91% | 91% |
|
|
89% | 86% | 86% |
|
|
89% | 87% | 86% |
|
|
89% | 86% | 86% |
|
|
89% | 91% | 91% |
|
|
89% | 91% | 89% |
|
|
89% | 89% | 89% |
|
|
89% | 88% | 91% |
|
|
89% | 80% | 80% |
|
|
89% | 92% | 92% |
|
|
90% | 85% | 85% |
|
|
90% | 92% | 91% |
|
|
90% | 86% | 90% |
|
|
90% | 95% | 95% |
|
|
90% | 81% | 81% |
|
|
90% | 92% | 92% |
|
|
90% | 86% | 86% |
|
|
90% | 80% | 80% |
|
|
90% | 91% | 91% |
|
|
90% | 91% | 91% |
|
|
90% | 91% | 91% |
|
|
91% | 93% | 95% |
|
|
91% | 94% | 93% |
|
|
91% | 95% | 92% |
|
|
91% | 90% | 90% |
|
|
91% | 88% | 88% |
|
|
92% | 92% | 83% |
|
|
92% | 94% | 87% |
|
|
92% | 94% | 93% |
|
|
93% | 91% | 90% |
|
|
93% | 95% | 95% |
|
|
93% | 89% | 89% |
|
|
93% | 99% | 99% |
|
|
93% | 95% | 95% |
|
|
93% | 98% | 98% |
|
|
93% | 86% | 86% |
|
|
93% | 72% | 72% |
|
|
93% | 96% | 95% |
|
|
93% | 92% | 92% |
|
|
94% | 92% | 92% |
|
|
94% | 94% | 94% |
|
|
94% | 96% | غير متاح |
|
|
94% | 91% | غير متاح |
|
|
94% | 99% | 99% |
|
|
94% | 96% | 96% |
|
|
95% | 93% | 93% |
|
|
95% | 97% | 96% |
|
|
95% | 96% | 96% |
|
|
95% | 94% | 94% |
|
|
95% | 99% | 95% |
|
|
95% | 97% | 97% |
|
|
95% | 90% | 90% |
|
|
95% | 99% | 99% |
|
|
96% | 94% | 94% |
|
|
96% | 97% | 97% |
|
|
96% | 97% | 97% |
|
|
96% | 95% | 95% |
|
|
96% | 89% | 85% |
|
|
96% | 85% | 84% |
|
|
96% | 93% | 93% |
|
|
96% | 96% | 96% |
|
|
96% | 97% | 96% |
|
|
96% | 97% | 99% |
|
|
96% | 97% | 97% |
|
|
96% | 96% | 86% |
|
|
96% | 92% | 92% |
|
|
96% | 97% | 97% |
|
|
97% | 99% | 99% |
|
|
97% | 98% | 98% |
|
|
97% | 95% | 95% |
|
|
97% | 97% | 97% |
|
|
97% | 94% | غير متاح |
|
|
97% | 94% | 94% |
|
|
97% | 97% | 97% |
|
|
97% | 97% | 97% |
|
|
97% | 98% | 98% |
|
|
97% | 94% | 94% |
|
|
97% | 97% | 96% |
|
|
97% | 97% | 97% |
|
|
97% | 94% | 94% |
|
|
97% | 94% | 94% |
|
|
97% | 94% | 94% |
|
|
98% | 98% | 97% |
|
|
98% | 98% | 98% |
|
|
98% | 98% | 96% |
|
|
98% | 99% | 99% |
|
|
98% | 97% | 99% |
|
|
98% | 93% | 93% |
|
|
98% | 96% | 96% |
|
|
98% | 99% | 97% |
|
|
98% | 97% | 97% |
|
|
98% | 96% | 93% |
|
|
98% | 97% | 97% |
|
|
99% | 96% | 96% |
|
|
99% | 99% | 99% |
|
|
99% | 99% | 99% |
|
|
99% | 94% | 94% |
|
|
99% | 98% | 98% |
|
|
99% | 99% | غير متاح |
|
|
99% | 98% | 98% |
|
|
99% | 96% | 96% |
|
|
99% | 99% | 98% |
|
|
99% | 99% | 99% |
|
|
99% | 99% | 99% |
|
|
99% | 99% | 99% |
|
|
99% | 99% | 99% |
|
|
99% | 96% | 96% |
|
|
99% | 99% | 99% |
|
|
99% | 97% | 97% |
|
|
99% | 99% | 99% |
|
|
99% | 98% | 99% |
|
|
99% | 90% | 88% |
من بين الدول الـ192 في القائمة، تبلغ أحدث نسبة تغطية بالجرعة الأولى من لقاح الحصبة أدناها في الجبل الأسود (23%)، وتصل إلى 99% في 19 دولة. وتقل النسبة عن 90% في 90 دولة، وتبلغ في نصف الدول 90% أو أكثر. في العالم، يتلقّى 84.3% من الأطفال بعمر 12–23 شهرًا الجرعة الأولى من لقاح الحصبة، و84.8% الجرعة الثالثة من لقاح DTP، و84.4% الجرعة الثالثة من لقاح التهاب الكبد B.
التغطية بالتطعيم هي نسبة الأطفال بعمر 12–23 شهرًا الذين تلقّوا جرعة معيّنة من لقاح ما: وهنا الجرعة الأولى من لقاح الحصبة (MCV1)، والجرعة الثالثة من اللقاح المضاد للخناق والكزاز والسعال الديكي (DTP3)، والجرعة الثالثة من لقاح التهاب الكبد B (HepB3). وتقدّرها منظمة الصحة العالمية واليونيسف كل سنة لكل دولة استنادًا إلى التقارير الوطنية والمسوح. وتبدأ القائمة بأدنى تغطية بلقاح الحصبة، لأن دولًا كثيرة تتساوى في أعلى القيم.
خرائط التغطية بالتطعيم حسب اللقاح
الحصبة، الجرعة الأولى (MCV1)، % من الأطفال بعمر 12–23 شهرًا
DTP3 (الخناق والكزاز والسعال الديكي؛ الجرعة الثالثة)، % من الأطفال بعمر 12–23 شهرًا
التهاب الكبد B، الجرعة الثالثة (HepB3)، % من الأطفال بعمر 12–23 شهرًا
على خريطة الجرعة الأولى من لقاح الحصبة، يصل التطعيم إلى أكثر من 95% من الأطفال في 67 دولة، وإلى أقل من 50% في 7 دول؛ وفي 1988 كان العددان 17 و35.
التطعيم ضد الحصبة (MCV1) في أكثر 5 دول سكانًا، % من الأطفال بعمر 12–23 شهرًا
| السنة | % من الأطفال | ||||
|---|---|---|---|---|---|
| الهند | الصين | الولايات المتحدة | باكستان | إندونيسيا | |
| 2024 | 97% | 95% | 92% | 86% | 85% |
| 2023 | 93% | 95% | 92% | 84% | 82% |
| 2022 | 95% | 99% | 92% | 82% | 92% |
| 2021 | 89% | 99% | 92% | 81% | 72% |
| 2020 | 89% | 99% | 91% | 83% | 76% |
| 2019 | 95% | 99% | 90% | 81% | 88% |
| 2018 | 93% | 99% | 92% | 79% | 89% |
| 2017 | 90% | 99% | 91% | 76% | 90% |
| 2016 | 88% | 99% | 92% | 75% | 88% |
| 2015 | 87% | 99% | 92% | 75% | 87% |
| 2014 | 85% | 99% | 92% | 71% | 86% |
| 2013 | 83% | 99% | 92% | 68% | 87% |
| 2012 | 83% | 99% | 91% | 63% | 82% |
| 2011 | 84% | 99% | 92% | 59% | 80% |
| 2010 | 82% | 99% | 92% | 57% | 78% |
| 2009 | 78% | 99% | 90% | 56% | 74% |
| 2008 | 72% | 97% | 92% | 56% | 76% |
| 2007 | 70% | 94% | 92% | 57% | 76% |
| 2006 | 69% | 93% | 92% | 59% | 79% |
| 2005 | 68% | 86% | 92% | 61% | 77% |
| 2004 | 64% | 86% | 93% | 63% | 76% |
| 2003 | 60% | 85% | 93% | 62% | 74% |
| 2002 | 56% | 85% | 91% | 60% | 72% |
| 2001 | 57% | 85% | 91% | 59% | 76% |
| 2000 | 56% | 84% | 91% | 57% | 76% |
| 1999 | 56% | 84% | 92% | 56% | 77% |
| 1998 | 53% | 83% | 92% | 54% | 77% |
| 1997 | 55% | 83% | 91% | 52% | 77% |
| 1996 | 66% | 84% | 91% | 50% | 79% |
| 1995 | 72% | 80% | 88% | 47% | 63% |
| 1994 | 67% | 75% | 89% | 53% | 66% |
| 1993 | 59% | 81% | 84% | 52% | 68% |
| 1992 | 51% | 87% | 83% | 52% | 65% |
| 1991 | 43% | 92% | 87% | 51% | 61% |
| 1990 | 56% | 98% | 90% | 50% | 58% |
| 1989 | 42% | 95% | 94% | 48% | 54% |
| 1988 | 32% | 95% | 98% | 46% | 51% |
| 1987 | 24% | 77% | 82% | 43% | 48% |
| 1986 | 10% | 63% | 97% | 41% | 45% |
| 1985 | 1% | 88% | 97% | 38% | 26% |
| 1984 | - | 84% | 98% | 33% | 13% |
| 1983 | - | 78% | 98% | 19% | 6% |
| 1982 | - | - | 97% | 3% | - |
| 1981 | - | - | 97% | 2% | - |
| 1980 | - | - | 86% | 1% | - |
تصل الجرعة الأولى من لقاح الحصبة إلى 97% من الأطفال بعمر 12–23 شهرًا في الهند، و95% في الصين، و92% في الولايات المتحدة، و86% في باكستان، و85% في إندونيسيا. ويبلغ الفرق بين الأعلى والأدنى بين الدول الـ5 12 نقطة مئوية، مقابل 96 في 1985.
التغطية بالتطعيم في العالم للأطفال بعمر سنة: الحصبة وDTP3 والتهاب الكبد B
| السنة | % من الأطفال | ||
|---|---|---|---|
| الحصبة (MCV1) | DTP3 | HepB3 | |
| 2024 | 84.3% | 84.8% | 84.4% |
| 2023 | 83% | 84.5% | 84.2% |
| 2022 | 83.7% | 85.1% | 84.7% |
| 2021 | 82% | 82.1% | 81.7% |
| 2020 | 83.9% | 83.5% | 83.3% |
| 2019 | 86.2% | 86.8% | 86% |
| 2018 | 86.4% | 86.6% | 84.4% |
| 2017 | 85.3% | 85.9% | 83.8% |
| 2016 | 85.1% | 85.9% | 84% |
| 2015 | 84.7% | 84.8% | 82.8% |
| 2014 | 84.3% | 84.7% | 81.2% |
| 2013 | 84% | 83.7% | 78.5% |
| 2012 | 83.9% | 84% | 79.1% |
| 2011 | 84.5% | 84.8% | 74.2% |
| 2010 | 83.9% | 83.7% | 72.6% |
| 2009 | 83.2% | 83.1% | 73% |
| 2008 | 80.8% | 81.1% | 69.2% |
| 2007 | 79.2% | 78.4% | 62.6% |
| 2006 | 78.8% | 78.4% | 57.6% |
| 2005 | 77.1% | 77.3% | 53.7% |
| 2004 | 75.7% | 76.4% | 48.6% |
| 2003 | 73.7% | 74.4% | 44% |
| 2002 | 72.1% | 72.7% | 37.4% |
| 2001 | 72.5% | 73% | 31.9% |
| 2000 | 71.5% | 72.3% | 29.5% |
| 1999 | 71.3% | 71.8% | 18.4% |
| 1998 | 70.6% | 71.4% | 15.4% |
| 1997 | 71.1% | 71.5% | 14.6% |
| 1996 | 73.2% | 72.3% | 13.4% |
| 1995 | 73.4% | 73.2% | 11.4% |
| 1994 | 71.6% | 72.8% | 7.6% |
| 1993 | 70% | 70.4% | 4.3% |
| 1992 | 69.4% | 70.5% | 2.5% |
| 1991 | 68.9% | 71.9% | 1.2% |
| 1990 | 72.7% | 76% | 0.6% |
| 1989 | 67.1% | 68.4% | 0.3% |
| 1988 | 61.5% | 63.3% | 0% |
| 1987 | 51.9% | 54.3% | 0% |
| 1986 | 44.6% | 49.9% | 0% |
| 1985 | 43.9% | 46.7% | 0% |
| 1984 | 38.5% | 42.2% | - |
| 1983 | 34.4% | 35.9% | - |
| 1982 | 16.5% | 22.4% | - |
| 1981 | 15.5% | 20.1% | - |
| 1980 | 12.9% | 16.7% | - |
يتلقّى 84.3% من الأطفال بعمر 12–23 شهرًا في العالم الجرعة الأولى من لقاح الحصبة، و84.8% الجرعة الثالثة من لقاح DTP، و84.4% الجرعة الثالثة من لقاح التهاب الكبد B. وفي 1980 وصلت الجرعة الأولى من لقاح الحصبة إلى 12.9%، والجرعة الثالثة من لقاح DTP إلى 16.7%.
مقارنة معدلات التطعيم في أي دولتين
المصادر:
- البنك الدولي | الصحة (1980–2024، تحديث أكتوبر 2026)
المشاع الإبداعي - نسب المصنف (CC BY): يمكنك نسخ هذا المحتوى ومشاركته وتعديله وإعادة استخدامه، بما في ذلك للأغراض التجارية، بشرط ذكر statistics.wiki والإشارة إلى أي تغييرات أجريتها. قد تكون للمصادر المذكورة أعلاه شروط ترخيص خاصة بها.